- Home
- GNTA vs PETS Comparison
GNTA vs PETS Comparison
Compare GNTA & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNTA
- PETS
- Stock Information
- Founded
- GNTA 2014
- PETS 1996
- Country
- GNTA Italy
- PETS United States
- Employees
- GNTA N/A
- PETS N/A
- Industry
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- GNTA Health Care
- PETS Consumer Staples
- Exchange
- GNTA Nasdaq
- PETS Nasdaq
- Market Cap
- GNTA 67.4M
- PETS 82.0M
- IPO Year
- GNTA 2021
- PETS N/A
- Fundamental
- Price
- GNTA $5.34
- PETS $4.07
- Analyst Decision
- GNTA Strong Buy
- PETS Sell
- Analyst Count
- GNTA 1
- PETS 2
- Target Price
- GNTA $25.00
- PETS $3.50
- AVG Volume (30 Days)
- GNTA 28.4K
- PETS 182.6K
- Earning Date
- GNTA 01-01-0001
- PETS 11-06-2024
- Dividend Yield
- GNTA N/A
- PETS 29.41%
- EPS Growth
- GNTA N/A
- PETS N/A
- EPS
- GNTA N/A
- PETS N/A
- Revenue
- GNTA N/A
- PETS $270,772,000.00
- Revenue This Year
- GNTA N/A
- PETS N/A
- Revenue Next Year
- GNTA N/A
- PETS $3.27
- P/E Ratio
- GNTA N/A
- PETS N/A
- Revenue Growth
- GNTA N/A
- PETS 2.26
- 52 Week Low
- GNTA $2.20
- PETS $2.90
- 52 Week High
- GNTA $7.28
- PETS $8.27
- Technical
- Relative Strength Index (RSI)
- GNTA 56.89
- PETS 56.76
- Support Level
- GNTA $4.89
- PETS $3.78
- Resistance Level
- GNTA $6.20
- PETS $4.17
- Average True Range (ATR)
- GNTA 0.70
- PETS 0.18
- MACD
- GNTA -0.06
- PETS -0.01
- Stochastic Oscillator
- GNTA 37.32
- PETS 62.22
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.